v3.21.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 611,970 $ 228,713
Marketable securities, at fair value 190,710 67,546
Accounts receivable, net 102,922 106,843
Inventories 21,382 29,526
Prepaid assets 11,073 11,547
Other current assets 4,675 4,555
Total current assets 942,732 448,730
Property and equipment (net of accumulated depreciation of $98,746 and $92,895, respectively) 94,315 85,873
Operating lease right-of-use assets 50,904 45,786
Intangible assets, net 118,195 120,653
Goodwill 211,083 211,083
Restricted cash 11,119 21,919
Investment in non-consolidated affiliate 29,555 29,555
Loan receivable from non-consolidated affiliate 10,185 0
Prepaid lease asset 21,052 20,229
Other assets 5,273 4,503
Total non-current assets 551,681 539,601
Total assets 1,494,413 988,331
Current liabilities    
Accounts payable 18,919 24,965
Accrued compensation 23,621 24,727
Accrued expenses and other liabilities 14,018 11,654
Current portion of equipment financing obligations 2,089 2,841
Current portion of operating lease liabilities 5,111 4,967
Pharma contract liabilities 3,992 4,029
Total current liabilities 67,750 73,183
Long-term liabilities    
Convertible senior notes, net 530,378 168,120
Long-term debt, net 683 967
Operating lease liabilities 46,437 42,296
Deferred income tax liabilities, net 1,744 5,415
Other long-term liabilities 3,707 4,056
Total long-term liabilities 582,949 220,854
Total liabilities 650,699 294,037
Stockholders’ equity    
Common stock, $0.001 par value, (250,000,000 shares authorized; 117,136,654 and 112,075,474 shares issued and outstanding, respectively) 117 112
Additional paid-in capital 872,350 701,357
Accumulated other comprehensive (loss) income (150) 10
Accumulated deficit (28,603) (7,185)
Total stockholders’ equity 843,714 694,294
Total liabilities and stockholders' equity $ 1,494,413 $ 988,331

Source